Very recently, Leng et al. [40] demonstrated that cell subpopulation, which concurrently expresses CD44+, EpCAM+ and Lgr5+, displays self-renewal capacity in preclinical models of CRC. The gene discussed is CD44; the disease is colorectal carcinoma.